VBI Vaccines Inc/BC Earnings Per Share (Diluted)
VBI Vaccines Inc/BC reported Earnings Per Share (Diluted) of -$0.73 per share for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2024-05-15
- VBI Vaccines Inc/BC earnings per share, diluted for the quarter ending 2024-03-31 was -$0.73.
- VBI Vaccines Inc/BC earnings per share, diluted for the quarter ending 2023-12-31 was -$0.00.
- VBI Vaccines Inc/BC earnings per share, diluted for the quarter ending 2023-09-30 was -$1.01.
- VBI Vaccines Inc/BC earnings per share, diluted for the quarter ending 2023-06-30 was -$5.18.
- VBI Vaccines Inc/BC earnings per share, diluted for fiscal 2023 was -$6.03.
- VBI Vaccines Inc/BC earnings per share, diluted for fiscal 2022 was -$13.16.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$0.73 10-Q · filed 2024-05-15 | -$0.74 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.66 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$4.25 derived: net income ÷ weighted average shares · filed 2024-05-15 |
| 2023-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$0.91 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$3.65 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$6.03 10-K · filed 2024-04-16 |
| 2023-09-30 | -$1.01 10-Q · filed 2023-11-14 | -$4.37 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$7.30 10-Q · filed 2023-11-14 | -$9.70 derived: net income ÷ weighted average shares · filed 2024-05-15 |
| 2023-06-30 | -$5.18 10-Q · filed 2023-08-14 | -$8.41 10-Q · filed 2023-08-14 | -$10.86 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$13.79 derived: net income ÷ weighted average shares · filed 2024-05-15 |
| 2023-03-31 | -$3.22 10-Q · filed 2024-05-15 | -$5.68 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$8.61 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$13.92 derived: net income ÷ weighted average shares · filed 2024-05-15 |
| 2022-12-31 | -$2.46 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$5.38 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$10.69 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$13.16 10-K · filed 2024-04-16 |
| 2022-09-30 | -$2.93 10-Q · filed 2023-11-14 | -$8.24 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$10.71 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$5.31 10-Q · filed 2023-08-14 | -$7.78 10-Q · filed 2023-08-14 |